Roquefort Therapeutics (ROQ.L) Stock Price
£1.85 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Roquefort Therapeutics, AI stock picks, stock alerts and much more.
ROQ.L AI Stock Analysis
AI stock analysis for ROQ.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Roquefort Therapeutics (ROQ.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Roquefort Therapeutics (ROQ.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Roquefort Therapeutics (ROQ.L), currently trading at £1.85, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ROQ.L
-
Roquefort Therapeutics plc operates as a biotechnology research company.
-
Symbol
ROQ.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
2.9M
Similar Stocks
 |
Codexis 0I0X.L |
$2.24 1.1% |
4 |
 |
Oxford Nanopore Technologies plc ONT.L |
£119.3 2.3% |
6 |
 |
Sareum Holdings SAR.L |
£16 4.8% |
1 |
 |
Viridian Therapeutics 0K1R.L |
$13.26 0.5% |
5 |
 |
Avacta Group Plc AVCT.L |
£31.5 1.6% |
3 |
News
ROQ.L Alternative Data
Web Traffic
Roquefort Therapeutics receives an estimated 0 monthly visitors to roquefortinvest.com.
-
Web Traffic
0
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
Roquefort Therapeutics has 5,031 Twitter Followers on its main Twitter (also known as X) account, which is up by 4.8% over the last month.
-
Twitter Followers
5031
-
Daily Change
0.3%
-
1 Month Change
4.8%
-
3 Month Change
9.6%
News Mentions
Roquefort Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Roquefort Therapeutics has 4 employees.
-
LinkedIn Employees
4
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Roquefort Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
ROQ.L Financials
ROQ.L Key Metrics
-
Total Revenue
£0
-
Net Income
-£289.8K
-
Earnings per Share
-£0.0022
-
Free cash flow
-£262.3K
-
EBITDA
-£337.7K
-
EBITDA Ratio
0
-
Total Assets
£6.1M
ROQ.L 2-year Revenue & Income
ROQ.L 2-year Free Cash Flow
ROQ.L Technicals
ROQ.L SMA
ROQ.L RSI
FAQ
What's the current price of Roquefort Therapeutics (ROQ.L) Stock?
The price of an Roquefort Therapeutics (ROQ.L) share is £1.85.
What's the market cap of Roquefort Therapeutics?
The current market cap of Roquefort Therapeutics is 2.9M.
Should I buy or sell ROQ.L?
Roquefort Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Roquefort Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Roquefort Therapeutics a good investment?
The current analysis of Roquefort Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Roquefort Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Roquefort Therapeutics (ROQ.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Roquefort Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Roquefort Therapeutics (ROQ.L) that investors often compare it to?
Roquefort Therapeutics (ROQ.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Roquefort Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Roquefort Therapeutics' stock price to be around £1.79 in 2026. Starting from the current price of £1.85, this represents a 3.2% change in price, indicating a neutral outlook for the stock.
How to buy Roquefort Therapeutics (ROQ.L) Stock?
Roquefort Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Roquefort Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.